Description

The global downstream processing market size was estimated at USD 21.9 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 15.6% from 2021 to 2027. Downstream processing is the process of recovery and purification of the biosynthetic products. Biosynthetic products particularly pharmaceuticals, from natural sources such as plant or animal tissue or fermentation broth. Downstream processing market may also include recycling of salvageable components and proper treatment of waste. Furthermore, downstream processing is important step in manufacturing of hormones, antibiotics, antibodies, and vaccines. Stages include removal of insoluble, product isolation, product purification, product polishing and few recovery methods may be considered.  The market is expected to grow at significant rates owing to the rise in demand for biopharmaceutical products. The market is consolidated due to presence of the many companies competing with product innovations and advancements. Companies are focusing on the R&D and new product launches to increase their product portfolio. For instance, in November 2012, Asahi Kasie Medical Co. Ltd. Has launched 5 L QyuSpeed D membrane adsorbers, designed specifically for removal of impurities in bioprocessing. In the product segment, chromatographic columns and resins are expected to have significant growth rate owing to the technological advancements in chromatography techniques and new product launches.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX